logo

Last Update

This profile was last updated on 4/7/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Sanjay Shrivastava?

Sanjay Shrivastava

Director, Global Marketing

Medtronic , Inc.

HQ Phone:  (763) 514-4000

Direct Phone: (949) ***-****direct phone

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Medtronic , Inc.

710 Medtronic Parkway

Minneapolis, Minnesota,55432

United States

Company Description

Medtronic, Inc. is engaged in medical technology. The Company functions in seven operating segments that manufacture and sell device-based medical therapies. Its operating segments include Cardiac Rhythm Disease Management (CRDM); Spinal and Navigation; Neurol...more

Background Information

Employment History

Director of Research and Development

Ev3 Inc.


Manager

Abbott Laboratories company


Chair

Medical Device Task Force of the ASM International


Web References(18 Total References)


SABPA

www.sabpa.org [cached]

Dr. Sanjay Shrivastava, Director of R&D at EV3 Neurovascular and Dr. K.T. Rao, CSO and VP at Nellix Endovascular revealed the hottest technologies in endovascular aneurysm treatment.


India Currents

news.indiacurrents.com [cached]

TiEcon 2007 has made a concerted effort to feature emerging trends in the life sciences industry with "a keynote event, a distinguished speaker event, two panels and a networking luncheon," says Sanjay Shrivastava, R&D Manager, Abbott, and content team volunteer for TiEcon.


www.asminternational.org

The ASM Board of Trustees chartered a Task Force chaired by Sanjay Shrivastava, now of Abbott Laboratories.


Lecture | Conferences | iHEA | International Health Economics Association

www.healtheconomics.org [cached]

Sanjay Shrivastava, Ph.D., Principal Engineer, Abbott Vascular Devices, He will describe the impact of materials on the development of minimally invasive procedures and implants, which have replaced many complex surgical procedures during the past decade.
Vascular implants for peripheral vessels in particular have been impacted by Nitinol. This alloy has enhanced the development of minimally invasive procedures for the placement of vascular stents. Sanjay Shrivastava, Ph.D., Principal Engineer, Abbott Vascular Devices, He will describe the impact of materials on the development of minimally invasive procedures and implants, which have replaced many complex surgical procedures during the past decade. Vascular implants for peripheral vessels in particular have been impacted by Nitinol. This alloy has enhanced the development of minimally invasive procedures for the placement of vascular stents.


Cleveland Clinic Doctors and Materials Experts to Open Materials, Medicine, and Nanotechnology Summit

www.angeio.com [cached]

* Sanjay Shrivastava, Ph.D., Principal Engineer, Abbott Vascular Devices.Shrivastava was named one of the 100 most notable people in the medical device industry by Medical Device & Diagnostic Industry magazine and has been instrumental in developing materials for implantable medical devices.He will describe the impact of materials on the development of minimally invasive procedures and implants, which have replaced many complex surgical procedures during the past decade.Currently developing novel stent materials at Abbott Vascular Devices in Redwood City, California, Shrivastava also worked for Edwards Lifesciences on novel processes and materials for heart valves and peripheral stent applications.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory